A new method for pH triggered curcumin release by applying poly(l-lysine) mediated nanoparticle-congregation

Analytica Chimica Acta

Volumn 795, Issue , 2013, Pages 60-68

  Patra, Digambara ^a   Sleem, Fatima ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Curcumin; Drug delivery; Microcapsules; Nanoparticles; Poly l lysine

Indexed keywords

CURCUMIN; ENCAPSULATION EFFICIENCY; FLUORESCENCE MICROSCOPE IMAGES; MICROCAPSULES; PHOTOPHYSICAL BEHAVIOR; POLY-L-LYSINE; POORLY WATER-SOLUBLE DRUGS; SELF ASSEMBLED NANOPARTICLES;

ACETONE; ALKALINITY; AMINO ACIDS; DRUG DELIVERY; NANOPARTICLES; SOLS; SYNTHESIS (CHEMICAL);

ENCAPSULATION;

CURCUMIN; POLYLYSINE;

ARTICLE; CENTRIFUGATION; CONTROLLED STUDY; DEGRADATION; DISSOLUTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; FLOW RATE; FLUORESCENCE MICROSCOPY; HYDROPHOBICITY; MORPHOLOGY; NANOENCAPSULATION; NANOTECHNOLOGY; PARTICLE SIZE; PH; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SOLUBILITY; SPECTROPHOTOMETRY; TEMPERATURE;

CURCUMIN; DRUG DELIVERY; MICROCAPSULES; NANOPARTICLES; POLY-L-LYSINE;

ACETONE; CAPSULES; CURCUMIN; DRUG DELIVERY SYSTEMS; HYDROGEN-ION CONCENTRATION; NANOPARTICLES; PARTICLE SIZE; POLYLYSINE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; WATER;

EID: 84883220000     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2013.07.063     Document Type: Article

References (72)

1. Ammon H.P.T., Wahl M.A. Pharmacology of Curcuma longa. Planta Med. 1991, 57:1-7.
2. Eigner D., Scholz D. Ferula asa-foetida and Curcuma longa in traditional medicinal treatment and diet in Nepal. J. Ethnopharmacol. 1999, 67:1-6.
3. Pizzo P., Scapin C., Vitadello M., Florean C., Gorza L. Grp 94 acts as a mediator of curcumin-induced antioxidant defence in myogenic cells. J. Cell. Mol. Med. 2010, 14:970-981.
4. Sugiyama Y., Kawakishi S., Osawa T. Involvement of the diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. Biochem. Pharmacol. 1996, 52:519-525.
5. Srimal R.C., Dhawan B.N. Pharmacology of diferyloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J. Pharm. Pharmacol. 1973, 25:447-452.
6. Aggarwal B.B., Harikumar K.B. Potential therapeutic effects of curcumin: the anti-inflammatory agent against neurodegenerative cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int. J. Biochem. Cell Biol. 2009, 41:40-59.
7. Deodhar S.D., Sethi R., Srimal R.C. Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian J. Med. Res. 1980, 71:632-634.
8. Yang F., Lim G.P., Begum A.N., Ubeda O.J., Simmons M.R., Ambegaokar S.S., Chen P., Kayed R., Glabe C.G., Frautschy S.A., Cole G.M. J. Biol. Chem. 2005, 280(7):5892-5901.
9. Kiso Y., Suzuki Y., Watanabe N., Oshima Y., Hikino H. Antihepatotoxic principles of Curcuma longa rhizomes. Planta Med. 1983, 49:185-187.
10. Srivastava R., Dikshit M., Srimal R.C., Dhawan B.N. Antithrombotic effect of curcumin. Thromb. Res. 1985, 40:413-417.
11. Jordan W.C., Drew C.R. Curcumin: a natural herb with anti-HIV activity. J. Natl. Med. Assoc. 1996, 88:333-334.
12. De R., Kundu P., Swarnakar S., Ramamurthy T., Chowdhury A., Nair G.B., Mukhopadhyay A.K. Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob. Agents Chemother. 2009, 53:1592-1597.
13. Wang Y., Lu Z., Wu H., Lv F. Study on the antibiotic activity of microcapsule curcumin against foodborne pathogens. Int. J. Food Microbiol. 2009, 136:71-74.
14. Lee Y.K., Lee W.S., Hwang J.T., Kwon D.Y., Surh Y.J., Park O.J. Curcumin exerts antidifferentiation effect through AMPKR-PPAR-γ in 3T3-L1 adipocytes and antiproliferatory effect through AMPKRCOX-2 in cancer cells. J. Agric. Food Chem. 2009, 57:305-310.
15. Kuttan R., Sudheeran P.C., Josph C.D. Turmeric and curcumin as topical agents in cancer therapy. Tumori 1987, 73:29-31.
16. Shishodia S., Chaturvedi M.M., Aggarwal B.B. Role of curcumin in cancer therapy. Curr. Probl. Cancer. 2007, 31:243-305.
17. Chauhan S.C., Jaggi B.K., Jaggi M. Effect of curcumin on signaling pathways in cancer. Proc. South Dakota Acad. Sci. 2007, 86:283-293.
18. Karmakar S., Banik N.L., Patel S.J., Ray S.K. Curcumin activated both receptor-mediated and mitochondria-mediated proteolytic pathways for apoptosis in human glioblastoma T98G cells. Neurosci. Lett. 2006, 407:53-58.
19. Shishodia S., Amin H.M., Lai R., Aggarwal B.B. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem. Pharmacol. 2005, 70:700-713.
20. Deeb D.D., Jiang H., Gao X., Divine G., Dulchavsky S.A., Gautam S.C. Chemosensitization of hormone-refractory prostate cancer cells by curcumin to TRAIL-induced apoptosis. J. Exp. Ther. Oncol. 2005, 5:81-91.
21. Landis-Piwowar K.R., Milacic V., Chen D., Yang H., Zhao Y., Chan T.H., Yan B., Dou Q.P. The proteasome as a potential target for novel anticancer drugs and chemosensitizers. Drug Resist. Update 2006, 9:263-273.
22. Liang G., Shao L., Wang Y., Zhao C., Chu Y., Xiao J., Zhao Y., Li X., Yang S. Exploration and synthesis of curcumin analogues with improved structural stability both in vitro and in vivo as cytotoxic agents. Bioorg. Med. Chem. 2009, 17:2623-2631.
23. Nardo L., Andreoni A., Bondani M., Masson M., Hjorth Tonnesen H. Studies on curcumin and curcuminoids. XXXIV. Photophysical properties of a symmetrical, non-substituted curcumin analogue. J. Photochem. Photobiol. B 2009, 97:77-86.
24. Shankar T.N., Shantha N.V., Ramesh H.P., Murthy I.A., Murthy V.S. Toxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guineapigs & monkeys. Indian J. Exp. Biol. 1980, 18:73-75.
25. Qureshi S., Shah A.H., Ageel A.M. Toxicity studies on Alpinia galanga and Curcuma longa. Planta Med. 1992, 58:124-127.
26. Lao C.D., Ruffin T.T., Normolle D., Heath D.D., Murray S.I., Bailey J.M., Boggs M.E., Crowell J., Rock C.L., Brenner D.E. Dose escalation of a curcuminoid formulation. BMC Complement Altern. Med. 2006, 6:10.
27. Lopez-Lazaro M. Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Mol. Nutr. Food Res. 2008, 52:S103-S127.
28. Cheng A.L., Hsu C.H., Lin J.K., Hsu M.M., Ho Y.F., Shen T.S., Ko J.Y., Lin J.T., Lin B.R., Ming-Shiang W., Yu H.S., Jee S.H., Chen G.S., Chen T.M., Chen C.A., Lai M.K., Pu Y.S., Pan M.H., Wang Y.J., Tsai C.C., Hsieh C.Y. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001, 21:2895-2900.
29. Wahlstrom B., Blenow G. A study on the fate of curcumin in rat. Pharmacol. Toxicol. 1978, 43:86-92.
30. Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: problems and promises. Mol. Pharm. 2007, 4:807-818.
31. Anand P., Nair H.B., Sung B., Kunnumakkara A.B., Yadav V.R., Tekmal R.R., Aggarwal B.B. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem. Pharmacol. 2010, 79:330-338.
32. Wang D., Veena M.S., Stevenson K., Tang C., Ho B., Suh J.D., Duarte V.M., Faull K.F., Mehta K., Srivatsan E.S., Wang M.B. Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor κB by an AKT-independent pathway. Clin. Cancer Res. 2008, 14:6228-6236.
33. Gupta V., Aseh A., Rios C.N., Aggarwal B.B., Mathur A.B. Fabrication and characterization of silk fibroin-derived curcumin nanoparticles for cancer therapy. Int. J. Nanomed. 2009, 4:115-122.
34. Das R.K., Kasoju N., Bora U. Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine 2010, 6:153-160.
35. Maiti K., Mukherjee K., Gantait A., Saha B.P., Mukherjee P.K. Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int. J. Pharm. 2007, 330:155-163.
36. Yallapu M.M., Jaggi M., Chauhan S.C. Poly(β-cyclodextrin)/curcumin self-assembly: a novel approach to improve curcumin delivery and its therapeutic efficacy in prostate cancer cells. Macromol. Biosci. 2010, 10:1141-1151.
37. Clifford N.W., Iyer K.S., Raston C.L. Encapsulation and controlled release of nutraceuticals using mesoporous silica capsules. J. Mat. Chem. 2008, 18:162-165.
38. Bisht S., Mizuma M., Feldmann G., Ottenhof N.A., Hong S.-M., Pamanik D., Chenna V., Karikari C., Sharma R., Goggins M.G., Rudek M.A., Ravi R., Maitra A., Maitra A. Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer. Mol. Cancer Ther. 2010, 9:2255-2264.
39. Bisht S., Feldmann G., Soni S., Ravi R., Karikar C., Maitra A., Maitra A. Polymeric nanoparticle-encapsulated curcumin (nanocurcumin): a novel strategy for human cancer therapy. J. Nanobiotechnol. 2007, 5:3-21.
40. Yallapu M.M., Gupta B.K., Jaggi M., Chauhan S.C. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J. Colloid Interface Sci. 2010, 351:19-29.
41. Bhawana R.K., Basniwal H.S., Buttar V.K., Jain N. Curcumin nanoparticles: preparation, characterization, and antimicrobial study. J. Agric. Food Chem. 2011, 59:2056-2061.
42. Bagariaa H.G., Wong M.S. Polyamine - salt aggregate assembly of capsules as responsive drug delivery vehicles. J. Mater. Chem. 2011, 21:9454-9466.
43. Mann S., Ozin G.A. Synthesis of inorganic materials with complex form. Nature 1996, 382:313-318.
44. Whitesides G.M., Boncheva M. Beyond molecules: self-assembly of mesoscopic and macroscopic components. Proc. Natl. Acad. Sci. USA 2002, 99:4769-4774.
45. Shenhar R., Rotello V.M. Nanoparticles: scaffolds and building blocks. Acc. Chem. Res. 2003, 36:549-561.
46. Murray C.B., Kagan C.R., Bawendi M.G. Self-organization of CdSe nanocrystallites into three-dimensional quantum dot superlattices. Science 1995, 270:1335-1338.
47. Hassenkam T., Norgaard K., Iversen L., Kiely C.J., Brust M., Bjornholm T. Fabrication of 2D gold nanowires by self-assembly of gold nanoparticles on water surfaces in the presence of surfactants. Adv. Mater. 2002, 14:1126-1130.
48. Boal A.K., Ilhan F., DeRouchey J.E., Thurn-Albrecht T., Russell sF T.P., Rotello V.M. Self-assembly of nanoparticles into structured spherical and network aggregates. Nature 2000, 404:746-748.
49. Wong M.S., Cha J.N., Choi K.S., Deming T.J., Stucky G.D. Assembly of nanoparticles into hollow spheres using block copolypeptides?. Nano. Lett. 2002, 2:583-587.
50. Rana R.K., Murthy V.S., Yu J., Wong M.S. Nanoparticle self-assembly of heirarchically ordered microcapsule structures. Adv. Mater. 2005, 17:1145-1150.
51. Patra D., Amali A.J., Rana R.K. Preparation and photophysics of HPTS-based nanoparticle-assembled microcapsules. J. Mater. Chem. 2009, 19:4017-4021.
52. Amali A.J., Rangaraj N., Patra D., Rana R.K. Pyranine-3 in poly(l-lysine)-mediated nanoparticle - assembled microcapsules: its pH sensitive release while acting as a ratiometric optical pH sensor. Chem. Commun. 2012, 48:856-858.
53. Amali A.J., Saravanan P., Rana R.K. Tailored anisotropic magnetic chain structures hierarchically assembled from magnetoresponsive and fluorescent components. Angew. Chem. Int. Ed. 2011, 50:1318-1321.
54. Amali A.J., Awwad N.H., Rana R.K., Patra D. Nanoparticle assembled microcapsules for application as pH and ammonia sensor. Anal. Chim. Acta 2011, 708:75-83.
55. Ryser H.J., Shen W.C. Conjugation of methotrexate to poly(l-lysine) increases drug transport and overcomes drug resistance in cultured cells. Proc. Natl. Acad. Sci. USA 1978, 75:3867-3870.
56. Ryser H.J., Shen W.C. Conjugation of methotrexate to poly(l-lysine) as a potential way to overcome drug resistance. Cancer 1980, 15(45):1207-1211.
57. Benesi M.L., Hildebrand J.H. A spectrophotometric investigation of the interaction of iodine with aromatic hydrocarbons. J. Am. Chem. Soc. 1949, 71:2703-2707.
58. Patra D., Barakat C., Tafech R.M. Study on effect of lipophilic curcumin on sub-domain IIA site of human serum albumin during unfolded and refolded states: a synchronous fluorescence spectroscopic study. Colloids Surf. B: Biointerfaces 2012, 94:354-361.
59. Patra D., Barakat C. Time-resolved fluorescence study during denaturation and renaturation of curcumin-myoglobin complex. Int. J. Biol. Macromol. 2012, 50:885-890.
60. Shen L., Ji H.F. Theoretical study on physiochemical properties of curcumin. Spectrochim. Acta A: Mol. Biomol. Spectrosc. 2007, 67:619-623.
61. Patra D., Barakat C. Unique role of ionic liquid [bmin][BF4] during curcumin - surfactant association and micellization of cationic, anionic and non-ionic surfactant solutions. Spectrochim. Acta A: Mol. Biomol. Spectrosc. 2011, 79:1823-1828.
62. Patwardhan S.V., Mukherjee N., Steinitz-Kannan M., Clarson S.J. Bioinspired synthesis of new silica structures. Chem. Commun. 2003, 1122-1123.
63. Yu J., Javier D., Yassen M.A., Nitin N., Richards-Kortum R., Anvari B., Wong M.S. Self-assembly synthesis, tumor cell targeting and photothermal capabilities of antibody-coated indocyanine green nanocapsules. J. Am. Chem. Soc. 2010, 132:1929-1938.
64. Kolev T.M., Velcheva E.A., Stamboliyska B.A., Spiteller M. DFT and experimental studies of the structure and vibrational spectra of curcumin. Int. J. Quant. Chem. 2005, 102:1069-1079.
65. Bich V.T., Thuy N.T., Binh N.T., Huong N.T.M., Yen P.N.D., Luong T.T. Structural and spectral properties of curcumin and metal-curcumin complex derived from turmeric (Curcuma longa). Phys. Engg. New Mater. Springer Proc. Phys. 2009, 127:271-278.
66. Jackson M., Haris P.I., Chapman D. Conformational transitions in poly(l-lysine) studies using Fourier transform infrared spectroscopy. Biochim. Biophys. Acta 1989, 998:75-79.
67. Deng X., Liu Y., Yuan M. Study on biodegradable polymer. 3. Synthesis and characterization of poly(dl-lacticacid)-co-poly(ethylene glycol)-co-poly(l-lysine) copolymer. Eur. Polym. J. 2002, 38:1435-1441.
68. 2 in SiC Whiskers by infrared absorption spectroscopy. Mater. Sci. Eng. A 1989, 114:209-221.
69. Patra D., Barakat C. Synchronous fluorescence spectroscopic study of solvatochromic curcumin dye. Spectrochim. Acta A: Mol. Biomol. Spectrosc. 2011, 79:1034-1041.
70. Higuchi T. Mechanism of sustained action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 1963, 52:1145-1148.
71. Ozcelik B., Lee J.H., Min D.B. Effects of light, oxygen, and pH on the absorbance of 2,2-diphenyl-1-picrylhydrazyl. J. Food Sci. 2003, 68:487-490.
72. Jovanovic S.V., Steenken S., Boone C.W., Simic M.G. H-atom transfer is a preferred antioxidant mechanism of curcumin. J. Am. Chem. Soc. 1999, 121:9677-9681.